Page last updated: 2024-08-24

capecitabine and Congenital Thrombotic Thrombocytopenic Purpura

capecitabine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arce-Lara, C; Bekaii-Saab, T; Cataland, S; Kraut, E; Ntukidem, N; Otterson, GA	1

Reviews

1 review(s) available for capecitabine and Congenital Thrombotic Thrombocytopenic Purpura

Article	Year
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Irinotecan; Mitomycin; Prospective Studies; Purpura, Thrombotic Thrombocytopenic	2010

Article

Year

Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.

Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Irinotecan; Mitomycin; Prospective Studies; Purpura, Thrombotic Thrombocytopenic

2010